TW201238603A - Method for preparation of 3-(2,3-dimethylphenyl)-2-butenal - Google Patents

Method for preparation of 3-(2,3-dimethylphenyl)-2-butenal Download PDF

Info

Publication number
TW201238603A
TW201238603A TW101107833A TW101107833A TW201238603A TW 201238603 A TW201238603 A TW 201238603A TW 101107833 A TW101107833 A TW 101107833A TW 101107833 A TW101107833 A TW 101107833A TW 201238603 A TW201238603 A TW 201238603A
Authority
TW
Taiwan
Prior art keywords
group
phenyl
different
alkyl
naphthyl
Prior art date
Application number
TW101107833A
Other languages
Chinese (zh)
Inventor
Doerwald Florencio Zaragoza
Stephan Elzner
Jeroen Alexander Dekker
Govert Arie Verspui
Ron Wilhelmus Hendrikus Dirks
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Publication of TW201238603A publication Critical patent/TW201238603A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/69Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by addition to carbon-to-carbon double or triple bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses the aldehyde 3-(2, 3-dimethylphenyl)-2-butenal, a method for its preparation from 1-bromo-2, 3-dimethylbenzene and crotonaldehyde, and its use in perfumes.

Description

201238603 六、發明說明: 本發明揭露醛類3-(2 3 _田〜、 、 1 ,·3-一甲本基)-2-丁烯醛、其從1 漠-2,3-—甲本以及巴豆酸的制供+ ^ 製備方法,及其在香水的用途< 在化妝品、香水以及士基_ μ + β 及大量的豕居用品中,芳香醛作為 香精香料被廣泛應用。α,β_不飽和芳香醛,例如經取代的肉 桂酿’其被認為具有獨特的芳香氣味,因此被使用於香水 工業。 W0 98/45237A揭露了某些芳香搭類,一種以苯乙晒乙 縮醛為原料出發,進而製備該等芳香醛類的方法,及其作 為香水的應用以及用於製備3 -芳基丙醛的中間體。其具有 類似麝香的氣味。201238603 VI. Description of the invention: The present invention discloses an aldehyde 3-(2 3 _田~, 1, 1 3-methyl-1-yl)-2-butenal, which is from 1 to 2,3-- And the preparation of crotonic acid + ^ preparation method, and its use in perfumes < In cosmetics, perfumes and Shiji _ μ + β and a large number of household products, aromatic aldehydes are widely used as flavors and fragrances. Alpha, β-unsaturated aromatic aldehydes, such as substituted meats, are considered to have a unique aromatic odor and are therefore used in the perfume industry. W0 98/45237A discloses certain aromatic blends, a process for preparing such aromatic aldehydes starting from phenylethyl acetal, and its use as a perfume and for the preparation of 3-arylpropionaldehyde Intermediates. It has a musky-like odor.

Littke 等人在 J. Am. Chem. Soc. 2001, 123, 6989-7000 中特別揭露了在Pd/P(t-Bu)3/Cy2NMe存在下,芳基溴化物 與α,β-不飽和酯的反應。在該公開内容中未提及將醛類作為 底物。 W0 03/048 1 07Α揭露了在存在把催化劑、符合空間構 象要求的含氮鹼基和偶極非質子溶劑的情況下,_原子與 烯烴發生反應。該烯烴的唯一例子是丙稀醯胺。Littke et al., J. Am. Chem. Soc. 2001, 123, 6989-7000, specifically discloses aryl bromides and α,β-unsaturated esters in the presence of Pd/P(t-Bu)3/Cy2NMe Reaction. No aldehydes are used as substrates in this disclosure. W0 03/048 1 07Α discloses the reaction of _ atoms with olefins in the presence of a nitrogen-containing base and a dipolar aprotic solvent that conform to the spatial conformation requirements. The only example of such an olefin is acrylamide.

Stadler 等人在 Synlett 2008,4,597-599 中揭露 了在存 在1莫耳當量的四丁基氣化銨、2 mol%的Pd(OAc)2和莫耳 量過剩的NaOAc的情況下,芳基溴化物與巴豆醛在NMP 201238603 浴劑中發生反應0當以2 、曱本作為方基溴化物時其具有 46% 的產率;當以 2 2,-Me,r η & * — ' 、Stadler et al., Synlett 2008, 4, 597-599, disclose the presence of 1 molar equivalent of tetrabutylammonium hydride, 2 mol% Pd(OAc)2, and excess molar NaOAc. The base bromide reacts with crotonaldehyde in NMP 201238603 bath. When using 2, transcript as the aryl bromide, it has a yield of 46%; when 2 2, -Me, r η & * — ' ,

MeaCeH3作為底物時其沒有產率。 香水及豕居用品工業對於能 八人產生興趣的、新型的 以及市場上不可獲得的新型 脅槓有持續地需求以提高香水 的可供選擇性以及滿足人彳門 疋人們對於香水日益變化的時尚需 求。更進-步地’各種物質需要被經濟地合成並且且有移 定的品質,因而需要高純度且具強烈氣味的香纟。本發明 提供不飽和芳㈣3_(2,3_二甲苯基)_2 丁 _,其具有 強烈的、令人產生興趣的芳香_味、強烈辛辣及甜味, 本發明還提供用於製備3_(2 3_ _ 、,J 一 T本基)-2-丁稀酿的一種 改良方法。 進一步地,確有需要一種用於製備3-(2,3-二甲苯基).2_ 丁烯醛的方法’其具有高產率,可減輕純化工藝的投入量, 提供一種高效率製備的可能。 在下文中, 鹵素疋指F、CM' Br或I,較佳地為α、Br或工; 如果沒有其他聲明,“烷基,,是指直鏈(linear)、支鏈 或環狀烧基;所述“院基”的例子包括甲基、乙基、正丙基、 異丙基、正丁基、二級丁基、第三丁基、戊基、己基、庚 基、環丙基、環丁基、環戊基、環己基、環庚基、降莰烷 基、金剛烷基,及其類似物。 環狀院基”被理解為包括環脂肪族、雙5衷脂肪族和三環 脂肪族的殘基; 如果沒有其他聲明,Ac是指乙酿(基);DIpEA是指 4 201238603 N-乙基-N,N-二異丙基胺;DABCO是指1,4-二氮二環[2.2.2] 辛烷;tBu是指第三丁基;DMF是指N,N-二曱基甲醢胺; NMP是指N-曱基-2-0比0各烧酮(pyrrolidone) ,1-曱基-2-0比嘻烧酮(pyrrolidone )或 N-甲基-2- 0比洛烧酮 (pyrrolidinone) ; DMA 是指 N,N-二甲基乙醯胺;THF 是 指四氫呋喃;以及dba是指1,5-二苯基戊-1,4-二烯-3-酮; 己烷是指各種已烷異構體的混合物。 術語“鈀源”和“Pd源,,具有相同含義而被使用。 本發明的目的在於提供一種用於製備式(I )化合物的 方法(A ),MeaCeH3 has no yield when it is used as a substrate. The perfume and habit industry has a continuing need for new and unobtainable new weight bars that are of interest to eight people to enhance the choice of perfumes and to satisfy the changing fashions of perfumes. demand. Further, the various substances need to be economically synthesized and have a shifted quality, thus requiring a high-purity and strong-scented toon. The present invention provides unsaturated aryl(tetra)3-(2,3-xylphenyl)_2-butan, which has a strong, interesting aromatic-taste, intense spicy and sweet taste, and the present invention also provides for the preparation of 3_(2) 3_ _ , , J - T base ) An improved method of 2-butan. Further, there is a need for a process for the preparation of 3-(2,3-dimethylphenyl).2-butenal which has a high yield, which reduces the amount of input to the purification process and provides a possibility of high-efficiency preparation. In the following, halogen 疋 means F, CM' Br or I, preferably α, Br or work; if not otherwise stated, "alkyl" means a linear, branched or cyclic alkyl group; Examples of the "hospital group" include methyl, ethyl, n-propyl, isopropyl, n-butyl, secondary butyl, tert-butyl, pentyl, hexyl, heptyl, cyclopropyl, and ring. Butyl, cyclopentyl, cyclohexyl, cycloheptyl, norbornyl, adamantyl, and the like. "cyclical" is understood to include cycloaliphatic, bis5, aliphatic and tricyclic fats. Residues of the family; if there is no other statement, Ac means ethyl (base); DIpEA means 4 201238603 N-ethyl-N,N-diisopropylamine; DABCO means 1,4-diazabicyclo [2.2.2] Octane; tBu means tributyl; DMF means N,N-dimercaptocaramine; NMP means N-mercapto-2-0 to 0 pyrrolidone, 1-mercapto-2-0 is compared to pyrrolidone or N-methyl-2-pyrrolidone; DMA means N,N-dimethylacetamide; THF means tetrahydrofuran And dba means 1,5-diphenylpentan-1,4-dien-3-one; hexane It refers to a mixture of various hexane isomers. The terms "palladium source" and "Pd source," have the same meaning and are used. It is an object of the present invention to provide a process (A) for the preparation of a compound of formula (I),

(I) 其中在式(I)中該被標記為(a)的雙鍵具有(z)或 (E)的構型;該方法(a)包含:式(Π )化合物與巴豆醛 在存在把源(Aa)和鹼(Ab)的情況下發生反應(a);(I) wherein in the formula (I) the double bond labeled (a) has a configuration of (z) or (E); the method (a) comprises: a compound of the formula (Π) and a crotonaldehyde in the presence Reaction (a) occurs in the case of source (Aa) and base (Ab);

(II) R1 是選自由 Cl、Br、I、0-S02-CF3、0-S02-C6H4-CH3 5 201238603 和0-S〇2_Ph組成的群组; 其中: 把源(Aa )是選自由载體上之Pd ( 0) 、Pd ( 〇 )錯合 物以及Pd ( Π )錯合物組成的群组; 驗(八1〇是選自由>1(112)(113)114、1,4-二氮二環[2.2.2;| 辛烷、羧酸鹽、碳酸鹽、碳酸氩鹽、磷酸、磷酸一氫或磷 酸二氫鈉鹽或鉀鹽’及其混合物組成的群组; R2、R3以及R4是相同的或不同且相互獨立的,其選 自由Η、C!·,5烷基、cs.6環狀烷基和苯基組成的群组。 較佳地’ R1是選自由氣、演和蛾組成的群组,更較佳 地,R1是氣或溴,進一步更較佳地,R1為溴。 如果所使用的鈀源(Aa )為載體上之Pd ( 0 ),該載體 較佳地為硫酸鋇或活性碳。 較佳地’該鈀源(Aa)是選自由PdCl2、 Pd(OAc)2、 Pd(dba)2、Pd2(dba)3、PdCl2(PhCN)2、PdCl2(MeCN)2、 PdCl2(PPh3)2、Pd(P(tBu)3)2、Pd2(P(tBu)3)3、Pd(P(l-金剛烷 基)3)2、Pd2(P(l-金剛烧基)3)3、Pd(PPh3)4和活性碳上之le 組成的群组; 更較佳地,選自由 PdCl2、 Pd(OAc)2、 Pd(dba)2、 Pd2(dba)3、PdCl2(PhCN)2、PdCl2(MeCN)2、PdCl2(PPh3)2、 Pd(P(tBu)3)2、Pd(P(l-金剛烷基)3)2、Pd(PPh3)4 組成的群组; 進一步更較侍地,選自由 Pd(OAc)2、 Pd(dba)2、 Pd2(dba)3、Pd(P(tBu)3)2、Pd(P(l-金剛烷基)3)2、PdCl2(MeCN)2 組成的群组; 6 201238603 特別地’該鈀源(Aa)為pd(〇Ac)2、 Pd2(dba)3和 Pd(P(tBu)3)2。 較佳地,該鹼(Ab)是選自由N(R2)(R3)R4、Μ·二氮 二環[2.2.2]辛烷、Ci. 1()羧酸鹽、碳酸鹽、碳酸氫鹽、磷酸、 構酸一氫或磷酸二氫鈉鹽或鉀鹽,及其混合物組成的群组; 更較佳地,該鹼(Ab)是選自由N_乙基·Ν,Ν_:異丙基 胺、心13、二氮二環[2.2.2]辛烷、队氺二甲基苯胺、二環己 基曱胺、二環己基胺、二異丙基胺、NaOAc、 Na2C03 ' NaHC03、 KOAc、 K2C03 和 K3P04 組成的群组; 進一步更較佳地,該鹼(Ab )是選自由N-乙基-ν,Ν-二異丙基胺、Net3、Ν,Ν-二曱基苯胺、二環己基甲胺、 NaOAc、Na2C03、NaHC03、KOAc、K2C03 和 κ3Ρ〇4 組成的群组; 特別地,選自由NaOAc、Ν-乙基-Ν,Ν-二異丙基胺、 Net3、組成的群组;更特別地,該鹼(Ab)為Na〇Ac或 N-乙基-N,N-二異丙基胺。 在一較佳實例中,該反應(A)的完成或進行未加入配 位基(Ac)或敍鹽(Ae)。 在另一較佳實例中,該反應(A )的完成或進行存在配 位基(Ac )。在該反應混合物中添加了配位基(),因 此該反應混合物包含鈀源(Aa )、鹼(Ab )和配位基(Ac )。 配位基(Ac )、鈀源(Aa )和驗(Ab )可以任一順序添加。 該配位基(Ac)為 p(R5)(R6)R7; 201238603 R5、R6和R7是相同的或不同且相互獨立的取代基, 其選自由下列取代基組成的群组:(II) R1 is a group selected from the group consisting of Cl, Br, I, 0-S02-CF3, 0-S02-C6H4-CH3 5 201238603 and 0-S〇2_Ph; wherein: the source (Aa) is selected from the group consisting of a group of Pd ( 0 ) , Pd ( 〇 ) complexes and Pd ( Π ) complexes on the body; test (8 1 〇 is selected from > 1 (112) (113) 114, 1, 4 a group consisting of diazabicyclo[2.2.2;|octane, carboxylate, carbonate, argon carbonate, phosphoric acid, monohydrogen phosphate or sodium dihydrogen phosphate or potassium salt, and mixtures thereof; R2 R3 and R4 are the same or different and independent of each other, and are selected from the group consisting of hydrazine, C!, 5-alkyl, cs.6 cyclic alkyl and phenyl. Preferably, 'R1 is selected from gas. More preferably, R1 is gas or bromine, and even more preferably, R1 is bromine. If the palladium source (Aa) used is Pd(0) on a carrier, the carrier Preferably, it is barium sulfate or activated carbon. Preferably, the palladium source (Aa) is selected from the group consisting of PdCl2, Pd(OAc)2, Pd(dba)2, Pd2(dba)3, PdCl2(PhCN)2, PdCl2. (MeCN)2, PdCl2(PPh3)2, Pd(P(tBu)3)2, Pd2(P(tBu)3)3, Pd(P(l-adamantyl)3)2, Pd2(P (1 - adamantyl) 3) 3, Pd(PPh3) 4 and a group of le on activated carbon; more preferably, selected from PdCl2, Pd(OAc)2, Pd(dba)2, Pd2( Dba)3, PdCl2(PhCN)2, PdCl2(MeCN)2, PdCl2(PPh3)2, Pd(P(tBu)3)2, Pd(P(l-adamantyl)3)2, Pd(PPh3) 4 group consisting of; further more than the servant, selected from Pd(OAc)2, Pd(dba)2, Pd2(dba)3, Pd(P(tBu)3)2, Pd(P(l-adamantane) Groups of 3)2, PdCl2(MeCN)2; 6 201238603 In particular, the palladium source (Aa) is pd(〇Ac)2, Pd2(dba)3 and Pd(P(tBu)3)2 Preferably, the base (Ab) is selected from the group consisting of N(R2)(R3)R4, ruthenium diazide [2.2.2] octane, Ci. 1 () carboxylate, carbonate, hydrogencarbonate a group consisting of salt, phosphoric acid, acid monohydrogen or sodium dihydrogen phosphate or potassium salt, and mixtures thereof; more preferably, the base (Ab) is selected from the group consisting of N_ethyl·Ν,Ν_:isopropyl Amine, heart 13, diazabicyclo[2.2.2]octane, quinone dimethylaniline, dicyclohexyl decylamine, dicyclohexylamine, diisopropylamine, NaOAc, Na2C03 'NaHC03, KOAc, a group consisting of K2C03 and K3P04; further preferably, the (Ab ) is selected from the group consisting of N-ethyl-ν, Ν-diisopropylamine, Net3, hydrazine, decyl-didecyl aniline, dicyclohexylmethylamine, NaOAc, Na2C03, NaHC03, KOAc, K2C03 and κ3Ρ〇 a group consisting of; in particular, selected from the group consisting of NaOAc, Ν-ethyl-hydrazine, hydrazine-diisopropylamine, Net3; more particularly, the base (Ab) is Na〇Ac or N -ethyl-N,N-diisopropylamine. In a preferred embodiment, the completion or progress of the reaction (A) is carried out without the addition of a ligand (Ac) or a salt (Ae). In another preferred embodiment, the completion of the reaction (A) or the presence of a ligand (Ac). A ligand () is added to the reaction mixture, and thus the reaction mixture contains a palladium source (Aa), a base (Ab), and a ligand (Ac). The ligand (Ac), the palladium source (Aa), and the test (Ab) may be added in any order. The ligand (Ac) is p(R5)(R6)R7; 201238603 R5, R6 and R7 are the same or different and mutually independent substituents selected from the group consisting of the following substituents:

Cu烷基; 苯基、聯苯基和萘基,該苯基、聯笨基和萘基為未經 取代的,或經由1、2、3或4個相同的或不同且相互獨立 的取代基所取代,該取代基選自由函素、烷基、Cl 4 烧氧基、氰基和硝基組成的群组; 二茂鐵基; 二茂鐵基取代二(第三丁基)膦; 雜芳基,s玄雜芳基為5或6員芳香族碳環,其具有— 或兩個内環的雜原子,該雜原子選自由〇、8和N組Cu alkyl; phenyl, biphenyl and naphthyl, the phenyl, biphenyl and naphthyl are unsubstituted, or via 1, 2, 3 or 4 identical or different and mutually independent substituents Substituted, the substituent is selected from the group consisting of a hydroxyl group, an alkyl group, a C 4 alkoxy group, a cyano group and a nitro group; a ferrocenyl group; a ferrocenyl-substituted di(t-butyl)phosphine; Aryl, s-heteroaryl is a 5- or 6-membered aromatic carbocyclic ring having - or two inner ring heteroatoms selected from the group consisting of ruthenium, 8 and N

組成的組所取代; C I -1 5烧氧基;Substituted by the group consisting of; C I -1 5 alkoxy;

成的組所取代;Replaced by a group;

’其具 硕暴組成的組所取代。 選自由0、S和N組成 2或3個相同的或不同 、Ci-4烷氧基、氰基和 8 201238603 較佳地,該配位基(Ac )選自由PBu3、P(〇-甲苯基)3、 PPh3、P(l-金剛烷基)3、P(Bu)(l-金剛烷基)2、三(2,4-二第 三丁基苯基)亞填酸鹽、P(tBu)2(2-聯苯基)、P(tBu)3、三(環 己基)膦、亞磷酸三苯酯、三(1-萘基)膦和ι,ι·-二(二_ 第三丁基膦基)_二茂鐵組成的群组; 更較佳地,選自由P(0-曱苯基)3、P(l_金剛烷基)3、 P(Bu)(l·金剛烷基)2、P(tBu)2(2-聯苯基)、P(tBu)3、三(環 己基)膦和三(1-萘基)膦組成的群组; 進一步更較佳地’選自由Ρ(〇·甲苯基)3、p(l_金剛烧 基)3、P(Bu)(l-金剛烧基)2、p(tBu)3 和 P(tBu)2(2-聯苯基)組 成的群组; 特別地,該配位基(Ac )為P(tBu)3。 在另一較佳實例中’反應(A )的完成或進行存在敍鹽 (Ae )。在該反應混合物中添加了銨鹽(Ae ),因此該反 應混合物包含鈀源(Aa )、鹼(Ab )和銨鹽(Ae )。銨鹽 (Ae )、把源(Aa )和鹼(Ab )可以任一順序添加。 銨鹽(Ae)是 N(R10)(R11)(R12)R13)+X-; 〇 Rll R12和R13是相同的或不同且相互獨立 的取代基’其選自由下列取代基組成的群组:Replaced by its group of violent violent. Optional 0, S and N constitute 2 or 3 identical or different, Ci-4 alkoxy, cyano and 8 201238603 Preferably, the ligand (Ac) is selected from PBu3, P (〇-tolyl) 3, PPh3, P(l-adamantyl) 3, P(Bu)(l-adamantyl) 2, tris(2,4-di-t-butylphenyl)-salt, P(tBu) 2) 2-(2-biphenyl), P(tBu)3, tri(cyclohexyl)phosphine, triphenyl phosphite, tris(1-naphthyl)phosphine and ι,ι·-二(二_三丁More preferably, selected from the group consisting of P(0-fluorenylphenyl)3, P(l-adamantyl)3, P(Bu)(l.adamantyl) a group consisting of 2, P(tBu) 2 (2-biphenyl), P(tBu) 3, tris(cyclohexyl)phosphine and tris(1-naphthyl)phosphine; further more preferably 'selected from Ρ(〇·tolyl)3, p(l_adamantyl)3, P(Bu)(l-adamantyl)2, p(tBu)3 and P(tBu)2(2-biphenyl) a group consisting of; in particular, the ligand (Ac) is P(tBu)3. In another preferred embodiment, the completion of the reaction (A) or the presence of a salt (Ae). An ammonium salt (Ae) is added to the reaction mixture, and thus the reaction mixture contains a palladium source (Aa), a base (Ab), and an ammonium salt (Ae). The ammonium salt (Ae), the source (Aa) and the base (Ab) may be added in either order. The ammonium salt (Ae) is N(R10)(R11)(R12)R13)+X-; 〇 Rll R12 and R13 are the same or different and mutually independent substituents' which are selected from the group consisting of the following substituents:

Cl-i5烷基; 苯基、聯苯基和萘基,該苯基、聯二苯基和萘基為未 經取代的,或經由丨、2、3或4個相同的或不同且相互獨 立的取代基所取代,該取代基選自由鹵素、cMo烷基、Ci 4 院氧基、氰基和硝基組成的群组; 201238603Cl-i5 alkyl; phenyl, biphenyl and naphthyl, the phenyl, biphenyl and naphthyl are unsubstituted, or via oxime, 2, 3 or 4 identical or different and independent Substituted by a substituent selected from the group consisting of halogen, cMo alkyl, Ci 4 alkoxy, cyano and nitro; 201238603

Cl-ΙΟ烯化芳基,Cl-ίο烯化芳基的芳基為笨基、聯苯基 或萘基’該苯基、聯苯基和萘基為未經取代的,或經由1、 2、3或4個相同的或不同且相互獨立的取代基所取代,該 取代基選自由鹵素、C^o烷基' C,.4烷氧基、氰基和硝基組 成的群组; X是選自由氟、氯、溴、磷酸鹽、磷酸氫鹽、磷酸二氫 鹽、•…羧酸鹽、硫酸鹽和硫酸氫鹽組成的群组;較佳地, X為選自由氣、溴、磷酸氫鹽、乙酸鹽和硫酸氫鹽組成的群 组。 較佳地, RIO、 Rll、 R12和R13是相同的或不同且相互獨立 的’其選自由下列基團組成的群组:Cl-decyl aryl, aryl of the aryl group of aryl is a strepto, biphenyl or naphthyl group. The phenyl, biphenyl and naphthyl groups are unsubstituted, or via 1, 2 Substituting 3 or 4 identical or different and mutually independent substituents selected from the group consisting of halogen, C^oalkyl 'C, .4 alkoxy, cyano and nitro; X Is selected from the group consisting of fluorine, chlorine, bromine, phosphate, hydrogen phosphate, dihydrogen phosphate, carboxylate, sulfate, and hydrogen sulfate; preferably, X is selected from the group consisting of gas, bromine, A group consisting of hydrogen phosphate, acetate, and hydrogen sulfate. Preferably, RIO, R11, R12 and R13 are the same or different and independent of each other' selected from the group consisting of:

Cl-I2烧基; 笨基’該苯基為未經取代的,或經由1或2個相同的 或不同且相互獨立的取代基所取代,該取代基選自由氟、 氯、演、C,·4烷基、C|-4烷氧基組成的群组; 苯甲基; X是選自由氟、氣、溴、磷酸鹽、磷酸氫鹽、磷酸二氫 鹽、碳原子數為1至1 〇的羧酸鹽、硫酸鹽和硫酸氫鹽組成 的群组;較佳地,X為選自由氣、溴、磷酸氫鹽、乙酸鹽和 硫酸氫鹽組成的群组。 更較佳地,該銨鹽(Ae )是選自由Bu4N+X_、Cl-I2 alkyl; a phenyl group which is unsubstituted or substituted by 1 or 2 identical or different and mutually independent substituents selected from the group consisting of fluorine, chlorine, and C. a group consisting of 4 alkyl groups, C|-4 alkoxy groups; benzyl group; X is selected from the group consisting of fluorine, gas, bromine, phosphate, hydrogen phosphate, dihydrogen phosphate, and having 1 to 1 carbon atoms. A group consisting of carboxylic acid salts, sulfates, and hydrogen sulfates; preferably, X is selected from the group consisting of gas, bromine, hydrogen phosphate, acetate, and hydrogen sulfate. More preferably, the ammonium salt (Ae ) is selected from the group consisting of Bu4N+X_,

MeN(Bu)3+X_、十二烷基-N(Me)3 + x-、苯甲基 n(Bu)3+X-、 笨甲基N(Me)3+X_和Me4N+X-組成的群组;並且X為選自 201238603 由氯、溴、磷酸氫鹽、乙酸鹽和硫酸氫鹽組成的群组。 更進一步較佳地,該銨鹽(Ae)是選自由Bu4N+x一、 MeN(Bu)3+X-、十二烷基-N(Me)3+x-、笨曱基 n(Bu)3+x_ 和苯甲基N(Me)3+X-組成的群组;並且χ為氣;更特別的 是該銨鹽(Ae)是Bu4N+Cr。 配位基(Ac)和銨鹽(Ae)兩者皆可存在於反應(A) 中 〇 在一較佳實例中,反應(A)的完成或進行中不存在溶 劑(Ad)。 在另一較佳實例中,反應(A)是在溶劑(Ad)中完成 或進行的。 該溶劑(Ad )為選自由DMF、NMP、DMA、N-甲基乙 醯胺、乙腈、丙腈、乙酸乙酯、乙酸丁酯、THF、甲基-四 氫呋喃、二氧六環、甲苯、二曱苯及其混合物組成的群组。 較佳地,s亥溶劑(Ad )為選自由j)MF、NMP、DMA、 N-曱基乙酿胺、乙猜和丙猜組成的群组; 更較佳地,該溶劑(Ad )為選自由DMF、NMP和DMA 組成的群组; 更特別的是該溶劑(Ad )為DMF或NMP » 在一較佳實施方式(PE 1 )中, 該鈀源(Aa)是Pd2(dba)3,,該鹼(Ab)是N-乙基-N,N- 二異丙基胺,以及該配位基(Ac)是p(tBu)3。 在另一較佳實施方式(PE2 )中,該鈀源(Aa )是 Pd(P(t-Bu)3)2,該鹼(Ab)是N-乙基·ν,Ν-二異丙基胺,更特 201238603 別的是,在該較佳實施方式中,未使用配位基(Ac)。 在另一較佳實施方式(PE3 )中,該鈀源(Aa )是 Pd(OAc)2,該鹼(Ab)是NaOAc,以及該銨鹽(Ae )是 Bu4N+C1_。 較佳地,在較佳實施方式(PEI) 、( PE2)和(PE3) 中所使用的溶劑(Ad )為DMF或NMP。 更較佳地,在較佳實施方式(PE〖)和(PE2 )中所使 用的溶劑(Ad )為DMF ;在較佳實施方式(PE3 )中所使 用的溶劑(Ad )為NMP。 通常情況下,反應(A )將產生式(j )化合物的(E ) 和(Z )兩種立體異構體的混合物。該兩種立體異構體可藉 由有機化學領域習知的傳統方法而分離。 較佳地,反應(A)的反應溫度為〇至2〇〇。〇,更較佳 地為10至150C,更進一步較佳地為2〇至13〇。匚。 較佳地,反應(A)是在常壓至1〇 bar的壓力下完成的, 更較佳地,其壓力為常壓至5 bar,更進一步較佳地為常壓 至 4 bar 〇 較佳地,該反應的進展藉由標準技術,例如核磁共 法(NMR)、紅外吸收光譜法(IR)、高效液相色譜 (HPLC)、液相色譜f譜法(LCMS)或薄層色譜法(T]U 監控》當起始原料的轉化率超過95%,或已無法再檢測 起始原料時’開始著手對反應混合物進行檢測。該等情 的發生所需要的時間取決於準確的反應溫度和二 催化劑的準確以,並且各批次之間的情況將會有所不^ 12 201238603 較佳地,反應(A)的反應時間為3〇分鐘至48小時, 更較佳地’為i小時至36小時’更進一步較佳地為2小時 至24小時。 較佳地’巴豆酿的莫耳量為式(n)化合物的莫耳量的 0.5至H)倍,更較佳地為!至5倍,更進一步較佳地為i 至3倍。 較佳地’以式(Π)化合物的莫耳量計,該鈀源…) 的量為0·01莫耳%至10莫耳%,更較佳地為〇」莫耳%至 5莫耳% ’更進一步較佳地為〇.3莫耳%至3莫耳%,特別 的是0.3莫耳%至1.2莫耳%。 較佳地,鹼(Ab)的莫耳量為式(η)化合物莫耳量 的0.5至5倍’更較佳地為丨至3倍,更進—步較佳地為【 至2倍。 較佳地,若反應(Α)中存在配位基(Ac),則該配位 基(Ac)的莫耳量為鈀源(Aa)莫耳量的〇」至7倍,更 較佳地為1至4倍,更進一步較佳地為1至21倍。 較佳地,若該反應(A)中存在銨鹽(Ae),則該銨鹽 (Ae)的莫耳量為式(π)化合物莫耳量的〇〇1至5倍, 更較佳地為0.05至2倍,更進一步較佳地為〇1至倍。 較佳地,溶劑(Ad)的量為式(n )化合物重量的〇 5 至50倍,更較佳地為2至40倍,更進一步較佳地為5至 3 5倍。 在另一較佳實施方式(PE 10)中, 巴旦盤的莫耳量為式(Π)化合物莫耳量的1至3倍; 13 201238603 以及 鈀源(Aa)的量為0.3莫耳%至3莫耳%,較佳地為〇3 莫耳%至1.2莫耳%’該莫耳%是以式(π)化合物的莫耳 量計;以及 鹼(Ab)的莫耳量為式(Π)化合物莫耳量的i至2 倍;以及 配位基(Ac)的莫耳量為鈀源(Aa)莫耳量的丨至4 倍,更較佳地為1至2.1倍。 在另一較佳實施方式(PE2〇)中, 巴旦醛的莫耳量為式(n)化合物莫耳量的】至3倍; 以及 。, ㈣(Aa)的量為〇·3莫耳%至3莫耳%,較佳地為㈠ 莫耳。/❶至i.2莫耳%,該莫耳%是以式(η)化合物 量計;以及 鹼(Ab)的莫耳量為式(η)化合物莫耳 倍。 ζ 在另一較佳實施方式(ΡΕ3〇)中, 1至3倍; 巴豆酸的莫耳量為式(Π)化合物莫耳量的 以及 纪源(Aa)的量為G.3莫耳%至3莫耳%,較佳地為Μ =/。至K2莫耳%,該莫耳%是以式")化 量計;以及 六’ 驗⑽的莫耳量為式(π)化合物莫耳量的 倍;以及 Ζ 201238603 録鹽(Ae)的莫耳量為式(π)化合物莫耳量的0.05 至2倍’更較佳地為〇丨至1 1倍。 • 較佳地,在較佳實施方式(ΡΕ10)、( ΡΕ20)和(ΡΕ30) 中’溶劑(Ad )的量為式(η )化合物重量的5至35倍。 在一更較佳實施方式(ΡΕ1-10)中, 實施方式(ΡΕ1 )與實施方式(ΡΕ10)相結合。 在另一更較佳實施方式(ΡΕ2-20)中, 實施方式(ΡΕ2 )與實施方式(ΡΕ20 )相結合。 在另一更較佳實施方式(ΡΕ3-30)中, 實施方式(ΡΕ3 )與實施方式(ΡΕ30)相結合。 進一步更特別的是,在實施方式(PEl_l〇 )、( ΡΕ2-20 ) 和(ΡΕ3-30 )中,溶劑(Ad)為 dmf 或 ΝΜΡ。 更特別的是,在實施方式(ΡΕμο )和(PE2-20)中, 溶劑(Ad)為DMF ;在實施方式(PE3-30 )中溶劑(Ad) 為 ΝΜΡ 〇 在一進一步的具體實施方式中,當反應速率與其消耗 迷率相類似時,給入巴豆醛,當反應到式(π)化合物起始 莫耳1的至少5莫耳%,但不超過5〇莫耳%時巴豆醛的量 穩定不變’此時對應的速度是較佳的。 反應期間該反應混合物中巴豆醛的穩定量藉由標準技 術I測,較佳地其為線上監測或者取樣後經由紅外吸收光 普法(IR)、氣相色譜法(GC )或核磁共振法(NmR )監 測。 在進一步具體實施方式中,當配位元體(Ac )被使 15 201238603 用時’鈀源(Aa )和配位基(Ac )將於少量溶劑(Ad )中 經預混合’所述少量溶劑的量較佳地為〇·〇〇 1重量至20 重量-%,更較佳地為0.01重量-%至5重量-%,該重量_%表 示以所使用溶劑(Ad )的總重量計》較佳地,該預混合物 在溫度為0°C至1 〇〇°C下攪拌1至60分鐘,較佳地為20°C 至10 0 °C,然後將該預混合物添加至含有式(jj )化合物和 溶劑(Ad )的混合物中。 較佳地,該反應(A )是在惰性氣體條件下完成的。 繼該反應(A )之後,式(I )化合物藉由熟諳該項技 術者所習知的標準方法可從反應(A)所得反應混合物中分 離’例如從該反應混合物中蒸發易揮發性成分、用水稀釋 該反應混合物、酸化、萃取、洗滌、乾燥、濃縮、結晶、 蒸餾及其任一群组。 較佳地,酸化疋通過添加一種酸(A型酸化)而完成的, 較佳地為一種酸(A型酸化)的水性溶液。 較佳地,該酸(A型酸化)是選自由鹽酸和硫酸組成的 群组。 §玄酸(A型酸化)是一種常用於從反應混合物十分離有 機反應物的酸。 較佳地,該酸(Α型酸化)的添加量為能使所得混合物 的pH值達到〇至7,更較佳地為丨至4,更進一步較佳地 為2至4。 該鈀源(Aa )藉由將一不可溶性物質或一熟諳該項技 術者所習知的商業上可獲得的貴重金屬清除劑加入至反應 16 201238603 (A)所得反應混合物中可被選擇性地回收,該不可溶性物 例如活性炭或硫酸鋇’可鍵合鈀,然後濾除該載有鈀源(Aa ) 的不可溶性物質。 較佳地,該反應混合物中的易揮發性成分經減壓蒸發 而被去除。 任何水性液體的萃取較佳地是在具有溶劑(A_extr )下 完成的,溶劑(A-extr)是選自由甲苯、苯、二氣甲炫、氯 仿、乙酸C ! ·8院基酯及其混合物〗且成的群组。 較佳地,該乙酸c〗·8烷基酯是乙酸乙酸q 4烷基酯, 更較佳地是乙酸乙酯、乙酸異丙酯或乙酸丁醋。 該反應用水稀釋,酸化,然後用溶劑(A_extr)萃取, 然後濃縮,可選擇性地蒸餾該萃取物,從而分離得到式(j ) 化合物。 較佳地,在反應結束後的分離步驟期間,對於任何有 機相可選擇性地使用水或濃鹽水來完成洗滌。 更進一步較佳地,該反應混合物首先經減壓濃縮,然 後經稀釋’再以水性的酸進行酸化,然後用甲苯萃取。、 可選擇性地’任何有機相皆可被乾燥,較佳地用硫酸 鎂或硫酸鈉乾燥。 任何濃縮較佳的是藉由蒸館而實現的,較佳的是在減 壓條件下進行。 式(I )化合物可被純化’較佳的是藉由結晶或減壓蒸 在某些情況下’醛類是以其水合物型式而分離的。添 17 201238603 式(ϊ)化合物可能形 加水之後即在某些所涉分離參數下 成水合物型式’進行被分離。 使用本文中所描述的方法’通常將會得到e•和z_異構 體。該兩種異構體以及其混合物皆可用作香料。 本發明進—步的目的在於式(1)化合物,如上所定義 的式(I )化合物,以及所有較佳具體實施方式中的式(I ) 化合物,以及式(ϊ )化合物的z•異構體的混:物。 本發明進一步的目的在於W異構體作為香料的應 用’較佳地在香水或家居用品中的應用。 本發明進一步的目的在於式 你么八Q II )化合物用於製備式 (I)化合物的應用,其是藉由式几入 符田式I 化合物與巴豆醛的 反應。 本發明的方法使得單獨地構建式(1)化合物的整個碳 骨架成為-種可能,並且其具有高轉化率,其使用兩個分 子量類似的片段。若將其與線性的,階梯式的方法,例如 第WO 98/45237Α號專利中所描述的方法相比,本發明的方 法將提高其整體產率。此外,由於該兩個分子量類似的片 段是在合成的最後階段中使用的,因此容易從具有較高沸 點的式(I )化合物中將其分離,該方法所製備的最終產品 更容易被純化,並且更易獲得高芳香氣味純或高香精純的 型式,因為若該類似分子量的片段在中間步驟中使用而所 知·的最終產。α,則會形成碳_碳鍵。這對於作為香料而使用 的產品而言,是特別重要的。 由於該產品具有極其特別的芳香氣味,因而是香料工 201238603 業中一直追尋的非常卓越的產品。 實施例 方法: GC 裝置:Thermo Focus ; 柱子:RXi-5MS 15 m,ID 320 μπι,df 0.25 μιη ; 流速:2.5 ml/min ; 氣體載體:氦氣; 分流比:32 ; 進樣器溫度:230°C ; 進樣量:1 μΐ; 檢測:火焰電離; 檢測器溫度:250°C GC-方法: 起始溫度:60°C ;起始時間:2.〇 min;溫變率:4〇 K/min 終止溫度:250X:;最終進料時間:1〇 min; 1〇〇 μΐ反應混合物經由U ml乙腈(MeCN)稀釋, 用於氣相色譜(GC )分析以及產率的測定。 式(I)化合物(其系Z/E I娃 J3A ^、 A 、 ^ 異構體的混合物)的產率藉 由氣相色譜法’採用十四院作為肉祕1 4e、+ 況作為内標物,或者藉由核磁共 振法,使用化合物4-硝基笨曱搭 T峻作為參照物而測定的。為 了達到該目的’氣相色譜檢測玛认 它太^ 曰檢'則益的回應因數通過圖譜測 疋,產品峰面積與所有原料峰 到產率。 忖面積(之和)的對比計算得 在產率的測定中 式(I )化合物被用作參照物,其系 19 201238603 依據實施例1 c所製備,並通過下述方法進一步分離:該反 應混合物經過濾,減壓濃縮。所得殘餘物重新溶解於二氣 曱烷中,並用水和濃鹽水洗滌。該二氣甲烷相經濃縮,所 得殘餘物藉由柱層析法純化(矽膠柱,庚烷/乙酸乙醋:9 . 1) ’ 然後經減壓(bulb-to-bulb)蒸傭(140 到 180。匚,〇 12 mbar)。由 1.〇呂(5.4〇111111〇1)1-溴-2,3-二甲苯所生產的式(1) 化合物為〇_51g (產率為59% ),該式⑴化合物為幾乎無色 的油,通過氣相色譜法測定其純度為95%。 核磁共振氩譜(1 H-NMR)顯示該油為兩種立體異構體 的混合物。 1H NMR (400 MHz, CDC13) δ 2.16, 2.18, 2.22, 2.31, 2.45 (5 x s,9Η),5·94 以及 6.14 (2 x d,J = 8 Ηζ,1Η),6.93 (m,1H),7.12 (m,2H),9·22 以及 10.16 (2 x d,J = 8 Hz, 1H)。 實施例la到lh 於1-、;臭-2,3-二曱苯(100 mg,0.54 mmol)的混合物中,添 加巴豆醛(76 mg, 1.08 mmol)、十四烷(13.4 mg,内標物)及 溶劑(3.0 ml)、驗(0.8 1 mmol)和配位基溶液(0.2 M,0.054 mmol)以及溶於曱苯中的Pd2(dba)3 (0.014 mmol)。該混合 物在100。(:下被攪拌1 8 h。詳細結果如表!所示。 201238603 表1 實施例 配位基 驗 溶劑 式(I)化合物的產率 la P(2-tolyl)3 K2C〇3 DMF 11% lb P(t-Bu)3 NaOAc 二氧雜環已烷 29% lc P(t-Bu)3 DIPEA DMF 83% Id P(t-Bu)3 NaOAc 甲苯 13% le 正丁基二(1-金剛烷基)膦 NaOAc 二氧雜環已烷 15% If 亞磷酸三(2,4-二叔丁苯基)酯 K3PO4 DMF 26% 亞磷酸三(2,4-二叔丁笨基)酯 K2C03 DMF 24% lh 亞磷酸三(2,4-二叔丁苯基)酯 NaOAc DMF 21% 實施例2a到2f 於1-溴-2,3-二甲苯(100 mg, 0.54 mmol)的混合物中,添 加巴豆搭(76 mg,1.08 mmol)、十四烧(13.4 mg,内標物)及 溶劑 (3 · 0 m 1)、驗(0.8 1 m m ο 1)和配位基溶液(0 · 2 Μ, 0.01 lmmol)以及溶於甲苯中的 Pd2(dba)3 (0.0028 mmol)。該 混合物在1 00°C下被攪拌1 8 h。詳細結果如表2所示。 表2 實施例 配位基 鹼 溶劑 式(I)化合物的產率 2a 2-(二第三丁基磷酸)聯笨 NaOAc DMF 12% 2b P(2-tolyl)3 NaOAc DMF 18% 2c P(t-Bu)3 DIPEA DMF 78% 2d 三環已基膦 NaOAc DMF 5% 2e 三(1-蔡基)膦 NaOAc DMF 12% 2f 亞磷酸三(2,4-二叔丁苯基)酯 NaOAc DMF 4% 實施例3 a到3 e 於式(Π )化合物(0.64 mmol)的混合物中,添加巴豆 酿(76 mg,1.08 mmol)、十四烧(13.4 mg,内標物)及 DMF (3.0 21 201238603 ml)、DIPEA(0.81 mmol)和配位基溶液(0.2 M,0.0limm〇i) 以及溶於甲苯中的Pd源(0.0054mmol)。該混合物在i〇〇。0 下被攪拌2 1 h。詳細結果如表3所示。 表3 — ^ 實施例 配位基 Pd源 R1 式(I)化合物的產率 3a P(t-Bu)3 Pd(OAc)2 Br 30% 3b P(t-Bu"h PdCl2(PhCN)2 Br 34% 3c Pft-Bu)·, Pd on charcoal Br 48% 3d P(t-Bu), Pd(OAc)2 Cl 4% — 3e P(t-Bifh PdCl2(PhCN)2 Cl 3% ~~ 實施例4a到4f 於1->臭-2,3-二曱苯(1〇〇 mg,0.54 mmol)的混合物中,添 加巴豆酿(76 mg,1·〇8 mmol)、十四烧(13.4 mg,内標物)及 DMF (3.0 ml)、DIPEA(0.81 mmol)、Pd 源(0.0054mmol)和配 位基甲苯溶液,其濃度為每lml甲苯中含〇 2inm〇l配位基。 4混合物在1 〇〇°C下被攪拌1 8 h。詳細結果如表4所示。 表3 實施例 配位基 配位基與Pd 源的莫耳比 Pd源 式(I)化合物的產率 4a P(t-Bu)! 2 1 Pd2(dba)3 73% 4b P(t-Bu)^ 1 2 Pd/C 12% 4c P(t-Bu)^ 1 1 Pd/C 25% 4d P(t-Bu)3 1 2 Pd/C 44% 4e --- 0 1 Pd(P(t-Bu)3)2 82% 4f 0 1 Pd2Br2(P(t-Bu)3)4 30% 實施例5 22 201238603MeN(Bu)3+X_, dodecyl-N(Me)3 + x-, benzyl i(Bu)3+X-, stupid methyl N(Me)3+X_ and Me4N+X- a group consisting of; and X is a group selected from the group consisting of chlorine, bromine, hydrogen phosphate, acetate, and hydrogen sulfate selected from 201238603. Still more preferably, the ammonium salt (Ae) is selected from the group consisting of Bu4N+x-, MeN(Bu)3+X-, dodecyl-N(Me)3+x-, alum-based n(Bu) a group consisting of 3+x_ and benzyl N(Me)3+X-; and hydrazine is gas; more particularly, the ammonium salt (Ae) is Bu4N+Cr. Both the ligand (Ac) and the ammonium salt (Ae) may be present in the reaction (A). In a preferred embodiment, the solvent (Ad) is absent in the completion or in progress of the reaction (A). In another preferred embodiment, the reaction (A) is carried out or carried out in a solvent (Ad). The solvent (Ad) is selected from the group consisting of DMF, NMP, DMA, N-methylacetamide, acetonitrile, propionitrile, ethyl acetate, butyl acetate, THF, methyl-tetrahydrofuran, dioxane, toluene, and A group consisting of terpene and its mixtures. Preferably, the solvent (Ad) is selected from the group consisting of j) MF, NMP, DMA, N-mercaptoamine, B guess and C.; more preferably, the solvent (Ad) is Selecting a group consisting of DMF, NMP and DMA; more particularly the solvent (Ad) is DMF or NMP » In a preferred embodiment (PE 1 ), the palladium source (Aa) is Pd2(dba)3 The base (Ab) is N-ethyl-N,N-diisopropylamine, and the ligand (Ac) is p(tBu)3. In another preferred embodiment (PE2), the palladium source (Aa) is Pd(P(t-Bu)3)2, and the base (Ab) is N-ethyl·ν, Ν-diisopropyl Amine, more specific 201238603 In addition, in this preferred embodiment, no ligand (Ac) is used. In another preferred embodiment (PE3), the palladium source (Aa) is Pd(OAc)2, the base (Ab) is NaOAc, and the ammonium salt (Ae) is Bu4N+C1_. Preferably, the solvent (Ad) used in the preferred embodiments (PEI), (PE2) and (PE3) is DMF or NMP. More preferably, the solvent (Ad) used in the preferred embodiments (PE) and (PE2) is DMF; the solvent (Ad) used in the preferred embodiment (PE3) is NMP. Typically, reaction (A) will yield a mixture of the two stereoisomers (E) and (Z) of the compound of formula (j). The two stereoisomers can be separated by conventional methods well known in the art of organic chemistry. Preferably, the reaction temperature of the reaction (A) is from 〇 to 2〇〇. Further, it is more preferably from 10 to 150 C, still more preferably from 2 to 13 Å. Hey. Preferably, the reaction (A) is carried out at a pressure of from normal pressure to 1 Torr, more preferably, the pressure is from atmospheric pressure to 5 bar, still more preferably from atmospheric pressure to 4 bar. The progress of the reaction is carried out by standard techniques such as nuclear magnetic resonance (NMR), infrared absorption spectroscopy (IR), high performance liquid chromatography (HPLC), liquid chromatography f-spectroscopy (LCMS) or thin layer chromatography ( T]U Monitoring" When the conversion of the starting material exceeds 95%, or when it is no longer possible to detect the starting material, 'starting to test the reaction mixture. The time required for the occurrence depends on the exact reaction temperature and The accuracy of the two catalysts, and the situation between batches will be different. 12 201238603 Preferably, the reaction time of the reaction (A) is from 3 to 48 hours, more preferably 'i hours to 36 hours' is further preferably from 2 hours to 24 hours. Preferably, the amount of mulberry in the 'croton is 0.5 to H times the molar amount of the compound of the formula (n), more preferably! Up to 5 times, still more preferably i to 3 times. Preferably, the amount of the palladium source is from 0. 01 mol% to 10 mol%, more preferably from 〇 mol % to 5 mol, based on the molar amount of the compound of the formula (Π). % ' is further preferably from 〇.3 mol% to 3 mol%, in particular from 0.3 mol% to 1.2 mol%. Preferably, the molar amount of the base (Ab) is 0.5 to 5 times the molar amount of the compound of the formula (η)', more preferably 丨 to 3 times, and further more preferably [to 2 times. Preferably, if a ligand (Ac) is present in the reaction (Α), the molar amount of the ligand (Ac) is from 7 to 7 times the molar amount of the palladium source (Aa), more preferably It is 1 to 4 times, and more preferably 1 to 21 times. Preferably, if the ammonium salt (Ae) is present in the reaction (A), the molar amount of the ammonium salt (Ae) is from 1 to 5 times the molar amount of the compound of the formula (π), more preferably It is 0.05 to 2 times, and more preferably 〇1 to times. Preferably, the amount of the solvent (Ad) is 〇 5 to 50 times, more preferably 2 to 40 times, still more preferably 5 to 35 times the weight of the compound of the formula (n). In another preferred embodiment (PE 10), the molar amount of the batonic disk is 1 to 3 times the molar amount of the compound of the formula (Π); 13 201238603 and the amount of the palladium source (Aa) is 0.3 mol% Up to 3 mol%, preferably 〇3 mol% to 1.2 mol%', the mol% is based on the molar amount of the compound of the formula (π); and the molar amount of the base (Ab) is Π) i to 2 times the molar amount of the compound; and the molar amount of the ligand (Ac) is 4 times, more preferably 1 to 2.1 times, the enthalpy of the palladium source (Aa). In another preferred embodiment (PE2〇), the amount of molybdenum aldehyde is up to 3 times the molar amount of the compound of formula (n); (4) The amount of (Aa) is from 〇3 mol% to 3 mol%, preferably (a) mol. /❶ to i.2 mole %, the mole % is based on the compound of the formula (η); and the molar amount of the base (Ab) is the mole of the compound of the formula (η).另一 In another preferred embodiment (ΡΕ3〇), 1 to 3 times; the molar amount of crotonic acid is the molar amount of the compound of the formula (Π) and the amount of the source (Aa) is G. 3 mole% Up to 3 mol %, preferably Μ = /. To K2 mole %, the mole % is based on the formula "); and the molar amount of the six (test) (10) is a multiple of the molar amount of the compound of the formula (π); and Ζ 201238603 recorded salt (Ae) The molar amount is 0.05 to 2 times the molar amount of the compound of the formula (π), and more preferably 〇丨 to 11 times. • Preferably, the amount of solvent (Ad) in the preferred embodiments (ΡΕ10), (ΡΕ20) and (ΡΕ30) is from 5 to 35 times the weight of the compound of formula (η). In a more preferred embodiment (ΡΕ 1-10), the embodiment (ΡΕ1) is combined with the embodiment (ΡΕ10). In another more preferred embodiment (ΡΕ 2-20), the embodiment (ΡΕ2) is combined with the embodiment (ΡΕ20). In another more preferred embodiment (ΡΕ 3-30), the embodiment (ΡΕ3) is combined with the embodiment (ΡΕ30). Further more particularly, in the embodiments (PEl_l〇), (ΡΕ2-20) and (ΡΕ3-30), the solvent (Ad) is dmf or ΝΜΡ. More particularly, in the embodiments (ΡΕμο ) and (PE2-20), the solvent (Ad) is DMF; in the embodiment (PE3-30) the solvent (Ad) is ΝΜΡ in a further embodiment When the reaction rate is similar to its consumption rate, the amount of crotonaldehyde is administered to the crotonaldehyde when reacting to at least 5 mol% of the starting molybdenum of the formula (π), but not more than 5 mol%. Stable unchanged' at this time the corresponding speed is better. The stable amount of crotonaldehyde in the reaction mixture during the reaction is measured by standard technique I, preferably by on-line monitoring or after sampling by infrared absorption spectroscopy (IR), gas chromatography (GC) or nuclear magnetic resonance (NmR). )monitor. In a further embodiment, the palladium source (Aa) and the ligand (Ac) are premixed in a small amount of solvent (Ad) when the coordination element (Ac) is used by 15 201238603 'the small amount of solvent The amount is preferably from 重量·〇〇1 to 20% by weight, more preferably from 0.01% by weight to 5% by weight, based on the total weight of the solvent (Ad) used. Preferably, the premix is stirred at a temperature of 0 ° C to 1 ° C for 1 to 60 minutes, preferably 20 ° C to 100 ° C, and then the premix is added to the formula (jj) a mixture of a compound and a solvent (Ad). Preferably, the reaction (A) is carried out under inert gas conditions. Following the reaction (A), the compound of formula (I) can be isolated from the reaction mixture obtained in reaction (A) by standard methods known to those skilled in the art, for example, evaporating volatile components from the reaction mixture, The reaction mixture is diluted with water, acidified, extracted, washed, dried, concentrated, crystallized, distilled, and any group thereof. Preferably, the ruthenium hydride is accomplished by the addition of an acid (acidification of type A), preferably an aqueous solution of an acid (acidification of type A). Preferably, the acid (acidification of type A) is selected from the group consisting of hydrochloric acid and sulfuric acid. § Acid (A type acidification) is an acid commonly used to separate organic reactants from the reaction mixture. Preferably, the acid (indole acidification) is added in an amount such that the resulting mixture has a pH of from 〇 to 7, more preferably from 丨 to 4, still more preferably from 2 to 4. The palladium source (Aa) is selectively added by adding an insoluble material or a commercially available precious metal scavenger known to those skilled in the art to the reaction mixture obtained in Reaction 16 201238603 (A). Upon recovery, the insoluble matter such as activated carbon or barium sulfate' can be bonded to palladium, and then the insoluble matter carrying the palladium source (Aa) is filtered off. Preferably, the volatile components of the reaction mixture are removed by evaporation under reduced pressure. The extraction of any aqueous liquid is preferably carried out with a solvent (A-extr) selected from the group consisting of toluene, benzene, dioxane, chloroform, acetic acid C 8 · 8 esters and mixtures thereof 〗 and into groups. Preferably, the acetic acid c 8 alkyl ester is acetic acid q 4 alkyl ester, more preferably ethyl acetate, isopropyl acetate or butyl acetate. The reaction is diluted with water, acidified, then extracted with a solvent (A_extr), and then concentrated, and the extract is selectively distilled to thereby obtain a compound of the formula (j). Preferably, the washing is effected selectively with water or concentrated brine for any organic phase during the separation step after the end of the reaction. Still more preferably, the reaction mixture is first concentrated under reduced pressure, then diluted and then acidified with an aqueous acid, and then extracted with toluene. Alternatively, any organic phase can be dried, preferably with magnesium sulfate or sodium sulfate. Any concentration is preferably achieved by steaming, preferably under reduced pressure. The compound of formula (I) can be purified' preferably by crystallization or under reduced pressure. In some cases the aldehyde is isolated in its hydrated form. Add 17 201238603 A compound of the formula (ϊ) may be isolated after forming a hydrate form under water under certain separation parameters. The e• and z_ isomers will generally be obtained using the methods described herein. Both isomers, as well as mixtures thereof, can be used as perfumes. Further objects of the invention are the compounds of formula (1), the compounds of formula (I) as defined above, and the compounds of formula (I) in all preferred embodiments, and the z-isomerization of compounds of formula (ϊ) Mixed body: body. A further object of the invention is the use of the W isomer as a perfume' preferably in perfumery or household products. A further object of the present invention is the use of a compound of the formula (9) to prepare a compound of the formula (I) by reacting a compound of the formula I with a crotonaldehyde. The method of the present invention makes it possible to construct the entire carbon skeleton of the compound of the formula (1) alone, and it has a high conversion ratio, which uses two fragments having similar molecular weights. The method of the present invention will increase its overall yield if compared to a linear, stepwise process such as that described in WO 98/45237. Furthermore, since the two molecular weight-like fragments are used in the final stage of the synthesis, they are easily separated from the compound of the formula (I) having a higher boiling point, and the final product prepared by the method is more easily purified. It is also easier to obtain a high aromatic scent pure or high-purity type because the final production of the molecular weight-like fragment is known to be used in an intermediate step. α, a carbon-carbon bond is formed. This is especially important for products used as fragrances. Due to its extremely aromatic odor, this product is a very good product that has been pursued by the perfumer 201238603. EXAMPLES Method: GC apparatus: Thermo Focus; Column: RXi-5MS 15 m, ID 320 μπι, df 0.25 μιη; Flow rate: 2.5 ml/min; Gas carrier: Helium; Split ratio: 32; Injector temperature: 230 °C ; Injection volume: 1 μΐ; Detection: flame ionization; Detector temperature: 250 ° C GC-method: Starting temperature: 60 ° C; Starting time: 2. 〇 min; Temperature change rate: 4 〇 K /min termination temperature: 250X:; final feed time: 1 〇 min; 1 〇〇 μΐ reaction mixture was diluted with U ml acetonitrile (MeCN) for gas chromatography (GC) analysis and determination of yield. The yield of the compound of the formula (I), which is a mixture of Z/EI silane J3A ^, A, ^ isomers, is determined by gas chromatography 'using the fourteenth hospital as the meat secret 1 4e, + as the internal standard Or by the nuclear magnetic resonance method, using the compound 4-nitro astringent as a reference. In order to achieve this goal, the response factor of the gas chromatographic test is determined by the spectrum, and the product peak area and all the raw material peaks to the yield. Comparison of the area of the crucible (sum) The compound of formula (I) was used as a reference in the determination of the yield, which was prepared according to Example 1 c, and was further isolated by the following method: Filter and concentrate under reduced pressure. The residue obtained was redissolved in dioxane and washed with water and brine. The di-methane phase is concentrated and the residue obtained is purified by column chromatography (gel column, heptane / ethyl acetate: 9.1) and then reduced by bulb-to-bulb (140 to 180. 匚, 〇 12 mbar). The compound of the formula (1) produced by 1. 〇 (5.4〇111111〇1) 1-bromo-2,3-xylene is 〇_51g (yield 59%), and the compound of the formula (1) is almost colorless. The oil was found to have a purity of 95% by gas chromatography. Nuclear magnetic resonance argon (1 H-NMR) showed the oil to be a mixture of two stereoisomers. 1H NMR (400 MHz, CDC13) δ 2.16, 2.18, 2.22, 2.31, 2.45 (5 xs, 9Η), 5·94 and 6.14 (2 xd, J = 8 Ηζ, 1Η), 6.93 (m, 1H), 7.12 (m, 2H), 9·22 and 10.16 (2 xd, J = 8 Hz, 1H). Example la to lh In a mixture of 1-,; odor-2,3-diphenylbenzene (100 mg, 0.54 mmol), crotonaldehyde (76 mg, 1.08 mmol), tetradecane (13.4 mg, internal standard) And solvent (3.0 ml), test (0.8 1 mmol) and ligand solution (0.2 M, 0.054 mmol) and Pd2(dba)3 (0.014 mmol) dissolved in toluene. The mixture is at 100. (: The mixture was stirred for 18 h. The detailed results are shown in Table! 201238603 Table 1 Example Coordination Solvents The yield of the compound of formula (I) la P(2-tolyl)3 K2C〇3 DMF 11% lb P(t-Bu)3 NaOAc Dioxane 29% lc P(t-Bu)3 DIPEA DMF 83% Id P(t-Bu)3 NaOAc Toluene 13% le n-Butylbis(1-adamantane Phosphine NaOAc Dioxane 15% If Tris(2,4-di-tert-butylphenyl) phosphite K3PO4 DMF 26% Tris(2,4-di-tert-butyl) phosphite K2C03 DMF 24 % lh Tris(2,4-di-tert-butylphenyl) phosphite NaOAc DMF 21% Example 2a to 2f In a mixture of 1-bromo-2,3-xylene (100 mg, 0.54 mmol), add croton Take (76 mg, 1.08 mmol), fourteen burns (13.4 mg, internal standard) and solvent (3 · 0 m 1), test (0.8 1 mm ο 1) and ligand solution (0 · 2 Μ, 0.01 Lmmol) and Pd2(dba)3 (0.0028 mmol) dissolved in toluene. The mixture was stirred at 100 ° C for 18 h. The detailed results are shown in Table 2. Table 2 Example ligand base solvent (I) Yield of the compound 2a 2-(di-t-butylphosphoric acid)-linked stupid NaOAc DMF 12% 2b P(2-tolyl)3 NaOAc D MF 18% 2c P(t-Bu)3 DIPEA DMF 78% 2d Tricyclohexylphosphine NaOAc DMF 5% 2e Tris(1-Cai)phosphine NaOAc DMF 12% 2f Trisphosphite tris (2,4-di-tert-butyl) Phenyl) ester NaOAc DMF 4% Example 3 a to 3 e In a mixture of the compound of formula (Π) (0.64 mmol), croton (76 mg, 1.08 mmol), tetradecene (13.4 mg, internal standard) And DMF (3.0 21 201238603 ml), DIPEA (0.81 mmol) and ligand solution (0.2 M, 0.0 limm〇i) and a source of Pd (0.0054 mmol) dissolved in toluene. The mixture is in i. The mixture was stirred for 2 1 h. The detailed results are shown in Table 3. Table 3 - ^ Example ligand Pd source R1 Yield of the compound of formula (I) 3a P(t-Bu)3 Pd(OAc)2 Br 30 % 3b P(t-Bu"h PdCl2(PhCN)2 Br 34% 3c Pft-Bu)·, Pd on charcoal Br 48% 3d P(t-Bu), Pd(OAc)2 Cl 4% — 3e P( t-Bifh PdCl2(PhCN)2 Cl 3% ~~ Examples 4a to 4f in a mixture of 1-> odorous-2,3-diindenylbenzene (1 〇〇 mg, 0.54 mmol), added croton (76 Mg,1·〇8 mmol), fourteen burns (13.4 mg, internal standard) and DMF (3.0 ml), DIPEA (0.81 mmol), Pd source (0.0054 mmol) and ligand toluene The liquid has a concentration of in 2 inm〇l ligand per 1 ml of toluene. 4 The mixture was stirred at 1 ° C for 18 h. The detailed results are shown in Table 4. Table 3 Example molar ratio of ligand ligand to Pd source. Yield of compound of formula (I) 4a P(t-Bu)! 2 1 Pd2(dba)3 73% 4b P(t-Bu ) ^ 1 2 Pd/C 12% 4c P(t-Bu)^ 1 1 Pd/C 25% 4d P(t-Bu)3 1 2 Pd/C 44% 4e --- 0 1 Pd(P(t -Bu)3)2 82% 4f 0 1 Pd2Br2(P(t-Bu)3)4 30% Example 5 22 201238603

Pd(OAc)2 (5.3 mg,0.023 mmol)、N-甲基-2-。比咯院酮 (11.5 ml)、1-溴-2,3-二曱苯(0.405 g,2.18 mmol)、Bu4NC1 (0.3 82 g,1.3 8 mmol)、粉末狀的 NaOAc (0.22 g,2.68 mmol) 以及巴豆醛(0.31 g,4.43 mmol)的混合物在ll〇°C下攪拌 2h。將水性飽和NaHC03溶液(40 ml)加入其中,所得混合 物用甲苯萃取(3 X 20 ml) ^經合併的萃取物用濃鹽水洗滌一 次、加無水MgSCU乾燥’減壓條件下濃縮,即產出〇.79g 油。預期使用一定量的1-溴-2,3-二甲苯生成式(1)化合物的 里,產率為18〇/0,該1_>臭_2,3-二甲苯的使用量採用核磁共 振氫譜(1H-NMR)内標法測定。 【圖式簡單說明】 無 【主要元件符號說明】 無 23Pd(OAc)2 (5.3 mg, 0.023 mmol), N-methyl-2-. Bisalone (11.5 ml), 1-bromo-2,3-diindenyl (0.405 g, 2.18 mmol), Bu4NC1 (0.382 g, 1.3 8 mmol), powdered NaOAc (0.22 g, 2.68 mmol) A mixture of crotonaldehyde (0.31 g, 4.43 mmol) was stirred at ll ° C for 2 h. Aqueous saturated NaHC03 solution (40 ml) was added thereto, and the obtained mixture was extracted with toluene (3×20 ml). The combined extracts were washed once with concentrated brine, dried with anhydrous MgSCU and concentrated under reduced pressure to yield 〇 .79g oil. It is expected that a certain amount of 1-bromo-2,3-xylene can be used to form a compound of the formula (1) in a yield of 18 Å/0, and the amount of the odoro 2,3-xylene used is nuclear magnetic resonance hydrogen. Spectral (1H-NMR) internal standard method. [Simple description of the diagram] None [Key component symbol description] None 23

Claims (1)

201238603 七、申請專利範圍: 1 · 一種製備式(I )化合物的方法(A ),201238603 VII. Patent application scope: 1 · A method (A) for preparing a compound of formula (I), 其中’在式(I )中被標記為(a)的雙鍵具有(z) 或(E)之構型;方法(a)包括式(jj)化合物與巴豆酸 在把源(Aa)與鹼(Ab)存在下的反應(A);Wherein the double bond labeled as (a) in formula (I) has the configuration of (z) or (E); and the method (a) comprises the compound of formula (jj) with crotonic acid at the source (Aa) and base (Ab) the reaction in the presence of (A); R1 係選自由 Cl、Br、I、〇_s〇2-CF3、〇-S〇2_c6H4-cii3 和0-S02-Ph組成的群組; 其中: 在巴源(Aa)係選自由載體上之pd ( 〇 ) 、pd ( 〇)錯合 物以及Pd ( Π )錯合物組成的群組; 驗(Ab )係選自由 n(R2)(R3)R4、1,4-二氮二環[2.2·2] 辛院、羧酸鹽、碳酸鹽、碳酸氫鹽、碌酸鹽、構酸一氫或 鱗酸二氫納鹽或鉀鹽’及其混合物組成的群组; R2、R3以及R4是相同的或不同的且相互獨立地選自 由Η、Cl."院基' C5·6環烷基和苯基組成的群組。 24 201238603 2.根據申請專利範圍第丨項之方法(A ),其中 R1係選自由C卜Br和I組成的群組。 • 3.根據申請專利範圍第!或2項之方法(A),其中幻 為漠。 4. 根據申請專利範圍第i至3項中任一項之方法(a), 其中 該載體是硫酸鋇或活性碳。 5. 根據申請專利範圍第1至4項中任一項之方法(A), 其中 該把源(Aa)係選自由 PdCl2、pd(〇Ac)2、pd(dba)2、 Pd2(dba)3、PdCl2(PhCN)2、PdCl2(MeCN)2、PdCl2(PPh3)2、 Pd(P(tBu)3)2、Pd2(P(tBu)3)3、Pd(P(l-金剛烷基)3)2、pd2(p(1_ 金剛烷基)3)3、Pd(PPh3)4和活性碳上之鈀組成的群組。 6. 根據申請專利範圍第丨至5項中任項之方法, 其中 該驗(Ab)係選自由N_乙基_N,N_二異丙基胺、、 二氮二環[2.2.2]辛烷、N,N-二甲基苯胺、二環己基甲胺、二 環己基胺、二異丙基胺、Na〇Ac、 Na2C〇3、 ⑶3、 KOAc、 K2C03和Κ3Ρ04組成的群組。 7·根據申請專利範圍第1至6項中任一項之方法(Α ) ’ 其中 < «玄纪源(Aa )為Pd(P(tBu)3)2,且該驗(Ab )為N-乙 基-N,N-二異丙基胺。 8.根據申請專利範圍第1至7項任一項之方法 25 201238603 其中 反應(A)是在配位基(Ac)存在下完成; 配位基(Ac)為 P(R5)(R6)R7 ; R5、R6和R7是相同的或不同的且相互獨立地選自由 下列基團組成的群組: Cl-i5烷基; 苯基、聯苯基和萘基,該苯基、聯苯基和萘基為未經 取代或經1、2、3或4個相同或不同且相互獨立的取代基 所取代,其中該取代基係選自由齒素、Cii〇烷基、Ci4烷氧 基、氰基和硝基組成的群組; 二茂鐵基; 經二(第三丁基)膦取代的二茂鐵基; 雜芳基,该雜芳基為具有一或兩個内環雜原子的5或6 員芳香族碳環,其中該雜原子係選自由〇、s和N組成的群 組,該環係未經取代或經由丨、2或3個相同或不同且相互 獨立的取代基取代,其中該取代基係選自由函素、尸 基、Cu烷氧基、氰基和硝基組成的群組; C 1 -丨5院氧基; 0-苯基、0-聯苯基、〇_萘基,該〇_笨基、〇聯笨基 0·萘基係未經取代或經由i、2、3或4個相同或不同且 互獨立的取代基取代,其中該取代基係選自由鹵素、q 烧基、C 1 ·4院氧基、氰基和硝基組成的群組; 0-雜芳基,該0-雜关其盔 方丞為具有或兩個内環雜原子 5或6員芳香族碳環,其中該雜原子係選自由〇、s和ν 26 201238603 成的群組,該環係未經取代或經由丨、2或3個相同的或不 同且相互獨立的取代基取代,其中該取代基係選自由函 素、烷基、Cw烷氧基、氰基和硝基組成的群組。 9.根據申請專利範圍第8項之方法(a ),其中 a亥配位基(Ac)選自由PBu3、Ρ(0·甲苯基)3、pph3、_ 金剛烷基)3、P(Bu)(l-金剛烷基)2'三(2,4_二_第三丁基苯基) 亞磷酸鹽、P(tBu)2(2-聯苯基)、p(tBu)3、三(環己基)膦、 亞磷酸二苯酯、三(1_萘基)膦和^匕二(二_第三丁基膦基)_ 二茂鐵組成的群組。 1 〇 ·根據申請專利範圍第8項之方法(a ),其中 該配位基(Ac )是P(tBu)3。 11.根據申請專利範圍第8項之方法(A ),其中 該叙源(Aa )為Pd2(dba)3 ’該鹼(Ab )為N-乙基-Ν,Ν-二異丙基胺,且該配位基(Ac )是p(tBu)3。 12·根據申請專利範圍第1至7項中一或多項之方法 (A),其中 反應(A)是在敍鹽(Ae)存在下完成的; 銨鹽(Ae)是 n(R10)(R11)(R12)R13)+X-; Rl〇、Rll、R12和R13是相同或不同的且相互獨立的 選自由下列基團組成的群組: Ci-15烷基; 苯基、聯笨基和萘基,該苯基、聯苯基和萘基為未經 取代的,或經由1、2、3或4個相同或不同的且相互獨立 的取代基所取代,該取代基選自由函素、Cui〇烷基、c 27 201238603 院氧基、氰基和硝基組成的群組; c^o伸烷基芳基,該Ci_i()烯化芳基的芳基為苯基、聯 本基或萘基’ S玄本基、聯苯基和萘基為未經取代的,或經 由1、2、3或4個相同或不同的且相互獨立的取代基所取 代,該取代基選自由鹵素、Cl_1〇烷基、C| 4烷氧基、氰基和 硝基組成的群組; X係選自由F、C卜Br、磷酸鹽、磷酸氫鹽、磷酸二氫 鹽、C 1 1 Q绩酸鹽、硫酸鹽和硫酸氫鹽組成的群組。 1 3 .根據申請專利範圍第1 2項之方法(a ),其中 RIO、 Rll、 R12和R13是相同或不同的,且為相互 獨立的,其選自由下列基團組成的群組: C I -1 2烧基; 笨基’該苯基為未經取代或經由1或2個相同或不同 且相互獨立的取代基所取代’該取代基選自由F、Cl、Br、 C1 _4烷基、C , _4烷氧基組成的群組; 苯曱基; X是選自由F、Cl、Br、磷酸鹽、磷酸氫鹽、磷酸二氫 鹽、C i i 〇羧酸鹽、硫酸鹽和硫酸氫鹽組成的群組。 14_根據申請專利範圍第12項之方法(a),其中 該錄鹽(Ae)是選自由 Bu4N+X~、MeN(Bu)3+X_、十二 院基-N(Me)3+X-、苯曱基 n(Bu)3 + X'、苯甲基 N(Me)3H Me4N+X_組成的群組;並且χ為選自由c卜Br、磷酸氫鹽、 乙酸鹽和硫酸氫鹽組成的群組。 15.根據申請專利範圍第12項之方法(a),其中 28 201238603 該銨鹽(Ae )是 Bu4N+C1_。 16.根據申請專利範圍第12項之方法(a),其中 該把源(Aa)為Pd(〇Ac)2,該鹼(Ab )為Na〇Ac,且 該敍鹽(Ae)是 Bu4N+C1-。 17.根據申請專利範圍第!至16項中的一或多項之方去 (A) ’其中該反應(a)是在溶劑(Ad)中進行的.' N、曱基己 基'Tup、 該溶劑(Ad )係選自由DMF、NMP、DMA、 酿胺、乙腈、丙腈、乙酸乙酯、乙酸丁酯、THF、甲 二氧六環、曱苯、二曱苯及其混合物組成的群組 18. 根據申請專利範圍第17項之方法(A),其中 忒洛劑(Ad )為選自由DMF、NMP、DMA、甲基 醯胺、乙腈和丙腈組成的群組。 19. 根據申請專利範圍第17項之方法(Α),其中 。玄/谷劑(Ad )為DMF或ΝΜΡ 〇 八、圖式: 無 29R1 is selected from the group consisting of Cl, Br, I, 〇_s〇2-CF3, 〇-S〇2_c6H4-cii3 and 0-S02-Ph; wherein: the source of the source (Aa) is selected from a carrier a group consisting of a pd (〇), a pd (〇) complex, and a Pd (Π) complex; the test (Ab) is selected from n(R2)(R3)R4, 1,4-diazabicyclo[ 2.2·2] Group of Xinyuan, carboxylate, carbonate, bicarbonate, citrate, acid monohydrogen or dihydrogen sodium or potassium sulphate and mixtures thereof; R2, R3 and R4 They are the same or different and are independently selected from the group consisting of hydrazine, Cl. "homo-based C5·6 cycloalkyl and phenyl. The method of claim 3, wherein R1 is selected from the group consisting of Cb Br and I. • 3. According to the scope of the patent application! Or the method of 2 (A), in which the illusion is desert. 4. The method (a) according to any one of claims 1 to 3, wherein the carrier is barium sulfate or activated carbon. 5. The method (A) according to any one of claims 1 to 4, wherein the source (Aa) is selected from the group consisting of PdCl2, pd(〇Ac)2, pd(dba)2, Pd2(dba) 3. PdCl2(PhCN)2, PdCl2(MeCN)2, PdCl2(PPh3)2, Pd(P(tBu)3)2, Pd2(P(tBu)3)3, Pd(P(l-adamantyl) 3) 2. A group consisting of pd2 (p(1_adamantyl) 3)3, Pd(PPh3)4 and palladium on activated carbon. 6. The method according to any one of the preceding claims, wherein the test (Ab) is selected from the group consisting of N_ethyl_N,N-diisopropylamine, diazabicyclo[2.2.2 a group consisting of octane, N,N-dimethylaniline, dicyclohexylmethylamine, dicyclohexylamine, diisopropylamine, Na〇Ac, Na2C〇3, (3)3, KOAc, K2C03 and Κ3Ρ04. 7. The method according to any one of claims 1 to 6 (Α) 'where < «Xuan Jiyuan (Aa) is Pd(P(tBu)3)2, and the test (Ab) is N -ethyl-N,N-diisopropylamine. 8. The method according to any one of claims 1 to 7 of claim 25 201238603 wherein the reaction (A) is carried out in the presence of a ligand (Ac); the ligand (Ac) is P(R5)(R6)R7 R5, R6 and R7 are the same or different and are independently selected from the group consisting of: Cl-i5 alkyl; phenyl, biphenyl and naphthyl, the phenyl, biphenyl and The naphthyl group is unsubstituted or substituted by 1, 2, 3 or 4 identical or different and mutually independent substituents, wherein the substituent is selected from the group consisting of dentate, Cii decyl, Ci4 alkoxy, cyano a group consisting of a nitro group; a ferrocenyl group; a ferrocenyl group substituted with a di(tert-butyl)phosphine; a heteroaryl group which is 5 or 1 having one or two inner ring heteroatoms a 6-membered aromatic carbocyclic ring, wherein the hetero atom is selected from the group consisting of hydrazine, s, and N, the ring system being unsubstituted or substituted with hydrazine, 2 or 3 identical or different and independent substituents, wherein The substituent is selected from the group consisting of a phytochemical, a cadaveric group, a Cu alkoxy group, a cyano group, and a nitro group; a C 1 -丨5 oxime; 0-phenyl, 0-biphenyl, a naphthyl group, which is unsubstituted or substituted via i, 2, 3 or 4 identical or different and mutually independent substituents, wherein the substituent is selected from a group consisting of halogen, q alkyl, C 1 ·4 oxy, cyano and nitro; 0-heteroaryl, which is a heterocyclic ring having 5 or a 6-membered aromatic carbocyclic ring, wherein the hetero atom is selected from the group consisting of ruthenium, s, and ν 26 201238603, the ring system being unsubstituted or via hydrazine, 2 or 3 identical or different and independent substituents Substituted wherein the substituent is selected from the group consisting of a peptidin, an alkyl group, a Cw alkoxy group, a cyano group, and a nitro group. 9. The method (a) according to item 8 of the patent application, wherein the ahai ligand (Ac) is selected from the group consisting of PBu3, Ρ(0.tolyl)3, pph3, _adamantyl)3, P(Bu) (l-adamantyl) 2' tris(2,4-di-t-butylphenyl) phosphite, P(tBu)2(2-biphenyl), p(tBu)3, tri (ring) A group consisting of hexylphosphine, diphenyl phosphite, tris(1-naphthyl)phosphine, and bis(di-t-butylphosphino)-ferrocene. 1 〇 A method (a) according to item 8 of the patent application, wherein the ligand (Ac) is P(tBu)3. 11. The method according to claim 8 (A), wherein the source (Aa) is Pd2(dba)3', the base (Ab) is N-ethyl-oxime, Ν-diisopropylamine, And the ligand (Ac) is p(tBu)3. 12. Method (A) according to one or more of claims 1 to 7 wherein the reaction (A) is carried out in the presence of a salt (Ae); the ammonium salt (Ae) is n (R10) (R11) (R12)R13)+X-; Rl〇, R11, R12 and R13 are the same or different and are independently selected from the group consisting of Ci-15 alkyl; phenyl, phenyl and Naphthyl, the phenyl, biphenyl and naphthyl are unsubstituted or substituted by 1, 2, 3 or 4 identical or different and mutually independent substituents selected from the group consisting of C 〇 〇 alkyl, c 27 201238603 Group of alkoxy, cyano and nitro groups; c ^ o alkyl aryl, the aryl group of the Ci_i () alkylene aryl group is phenyl, hydrazino or Naphthyl 'S-decyl, biphenyl and naphthyl are unsubstituted or substituted by 1, 2, 3 or 4 identical or different and mutually independent substituents selected from halogens, a group consisting of Cl 1 decyl, C 4 alkoxy, cyano and nitro; X is selected from the group consisting of F, C, Br, phosphate, hydrogen phosphate, dihydrogen phosphate, C 1 1 Q acid Salt, sulfate and sulfuric acid Group salts thereof. 13. The method (a) according to claim 12, wherein RIO, R11, R12 and R13 are the same or different and are independent of each other selected from the group consisting of: CI - 1 2 alkyl; a phenyl group which is unsubstituted or substituted by 1 or 2 identical or different and mutually independent substituents selected from the group consisting of F, Cl, Br, C1 _4 alkyl, C a group consisting of _4 alkoxy groups; phenyl fluorenyl; X is selected from the group consisting of F, Cl, Br, phosphate, hydrogen phosphate, dihydrogen phosphate, C ii carboxylic acid salt, sulfate and hydrogen sulfate Group. 14_ According to the method (a) of claim 12, wherein the recorded salt (Ae) is selected from the group consisting of Bu4N+X~, MeN(Bu)3+X_, and twelve-base-N(Me)3+X a group consisting of benzoinyl n(Bu)3 + X', benzyl N(Me)3H Me4N+X_; and hydrazine is selected from the group consisting of c, Br, hydrogen phosphate, acetate and hydrogen sulfate The group consisting of. 15. Process (a) according to claim 12, wherein 28 201238603 the ammonium salt (Ae ) is Bu4N+C1_. 16. The method (a) of claim 12, wherein the source (Aa) is Pd(〇Ac)2, the base (Ab) is Na〇Ac, and the salt (Ae) is Bu4N+ C1-. 17. According to the scope of the patent application! To one or more of the items of 16 (A) 'wherein the reaction (a) is carried out in a solvent (Ad). 'N, decylhexyl' Tup, the solvent (Ad) is selected from DMF, Groups consisting of NMP, DMA, lanthanum, acetonitrile, propionitrile, ethyl acetate, butyl acetate, THF, methyldioxane, toluene, diphenylbenzene, and mixtures thereof 18. According to claim 17 The method (A) wherein the cockroach (Ad) is selected from the group consisting of DMF, NMP, DMA, methyl decylamine, acetonitrile, and propionitrile. 19. According to the method of claim 17 (Α), where. Xuan/Valent (Ad) is DMF or ΝΜΡ 〇 8. Pattern: None 29
TW101107833A 2011-03-10 2012-03-08 Method for preparation of 3-(2,3-dimethylphenyl)-2-butenal TW201238603A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161451177P 2011-03-10 2011-03-10
EP11001977 2011-03-10
US201161468655P 2011-03-29 2011-03-29
EP11002577 2011-03-29

Publications (1)

Publication Number Publication Date
TW201238603A true TW201238603A (en) 2012-10-01

Family

ID=46797518

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101107833A TW201238603A (en) 2011-03-10 2012-03-08 Method for preparation of 3-(2,3-dimethylphenyl)-2-butenal

Country Status (2)

Country Link
TW (1) TW201238603A (en)
WO (1) WO2012120070A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107428648A (en) * 2015-01-30 2017-12-01 坎布雷卡尔斯库加公司 Method for preparing such as compound of 3 aryl butyraldehyde that can be used for synthesis Medetomidine

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014205782A1 (en) 2013-06-28 2014-12-31 Givaudan Sa Organic compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19714042A1 (en) 1997-04-05 1998-10-08 Henkel Kgaa Process for the preparation of aromatic aldehydes
DE10159269A1 (en) 2001-12-03 2003-06-18 Bayer Ag Arylation of olefins

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107428648A (en) * 2015-01-30 2017-12-01 坎布雷卡尔斯库加公司 Method for preparing such as compound of 3 aryl butyraldehyde that can be used for synthesis Medetomidine

Also Published As

Publication number Publication date
WO2012120070A1 (en) 2012-09-13

Similar Documents

Publication Publication Date Title
CN104447599B (en) A kind of tetrazole heterogeneous ring compound and preparation method thereof
CN106365986B (en) Compound and preparation method thereof and the purposes in synthesis Bu Waxitan
TW509672B (en) Novel intermediate compounds and processes for the production of optical active octanoic acid derivatives
TW201210590A (en) Process for the preparation of pyrazole carboxylic acid amides
TW201238603A (en) Method for preparation of 3-(2,3-dimethylphenyl)-2-butenal
KR20220156560A (en) Synthesis of capsaicin derivatives
JP2010518077A (en) Process for the preparation of 2-substituted 5- (1-alkylthio) alkylpyridines
JP2007230963A (en) Method for producing 2,4-disubstituted pyridine
CN103402973B (en) Compound and production method thereof, and for the production of the method for Ro 64-0796/002
TWI848950B (en) Preparation method of fluorine-containing pyrazole derivatives and intermediates thereof
TWI314932B (en) New synthesis of a camptothecin subunit
JP6686050B2 (en) Borane complex and method for producing the same
KR102436961B1 (en) Process for the preparation of halo-substituted trifluoroacetophenones
TW200526577A (en) Processes for the preparation of N-substituted phthalimides
TW201217324A (en) Preparation of bicyclo[2.2.2]octan-2-one compounds
US10807941B2 (en) Process for the preparation of polysantol-type compounds
US10053426B2 (en) Process for the synthesis of metyrapone and alkylated metyrapone analogs
JP3281532B2 (en) Method for producing trans-3-isocamphylcyclohexanol
JP5151180B2 (en) 3,3 ', 4,4'-cyclohexenylphenyltetracarboxylic acid compound group and method for producing 3,3', 4,4'-biphenyltetracarboxylic acid compound
JP5205971B2 (en) Method for producing tetrahydropyran compound
Keiko et al. Synthesis and properties of 2-alkoxy-and 2-alkylthio-3-aryl (hetaryl) propenals
JP4958513B2 (en) Method for producing sedanenolide
Giurinia et al. Intramolecular Oxidative Diaryl Coupling of Tetrasubstituted Diphenylamines for the Preparation of Bis (trifluoromethyl) Dimethyl Carbazoles
IL303823A (en) Process of making organic compounds
JP5233675B2 (en) Process for producing optically active 2- (2'-piperidinyl) acetate